Futura Medical PLC (LSE:FUM) - Share price


Stock Report

Futura Medical PLC FUM

Last Price
GBX46.58

Day Change
-0.42|-0.89%

As of 18/05/2021
15:36:36 BST | GBX
Minimum 15 Minutes Delay.

Last Close47.00p
Day Range45.35 - 48.10
Mkt Cap120.80Mil
52-Wk Range12.11 - 84.00
Yield %-
ISINGB0033278473
Volume904,535
P/E-
P/S29.11
P/CF-0.14

Share Price

Total Returns 17/05/2021

 Chg (%)  
More ...
Futura Medical PLC-7.84 
FTSE 100 TR GBP0.44
 
Financials
201720182019
More ...
Income Statement
Turnover0.360.000.03
Operating Profit-4.86-7.27-11.16
Net Profit-3.90-5.88-8.92
Reported EPS-3.23-4.46-4.36
Balance Sheet
Current Assets9.5410.834.84
Non Current Assets0.060.050.06
Total Assets9.6110.884.90
Current Liabilities0.502.034.85
Total Liabilities---
Total Equity9.118.850.05
Cash Flow
Operating Cash Flow-5.03-5.64-8.02
Net Change in Cash-3.990.80-6.65
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
20/04/2021PurchaseMr. John Milne Clarke12.24129,75415,882.00
20/04/2021PurchaseMr. Jonathan David Freeman12.2446,5645,699.00

Company Profile

Futura Medical PLC is a drug manufacturer based in the United Kingdom. It lays primary focus exclusively on topically applied pharmaceutical drugs and medical devices which are developed using a highly efficient and proprietary transdermal delivery technology, DermaSys. DermaSys is a versatile technology that can be customized to suit the specific active compound being used and the therapeutic indication. Futura's products are used mainly for the treatment of erectile dysfunction and pain relief.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 18/05/2021

Annual Report
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-20,807.74
Op Mrgn-351.31
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive Director, ChairmanMr. John Milne Clarke
Executive Director, Chief ExecutiveMr James Henry Barder
Non-Executive DirectorMr. Jonathan David Freeman
Executive Director, Head of RandDMr. Kenneth William James
Executive Director, Finance Director and Chief Operating OfficerAngela Hildreth
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.